Liraglutide ameliorates cerebral ischemic injury in diabetic rats by regulating microglia/macrophage polarization through inhibition of NOX2 expression
Basic Medicine|更新时间:2026-01-09
|
Liraglutide ameliorates cerebral ischemic injury in diabetic rats by regulating microglia/macrophage polarization through inhibition of NOX2 expression
Journal of Army Medical UniversityVol. 44, Issue 11, Pages: 1136-1142(2022)
作者机构:
519100 广东 珠海,遵义医科大学第五附属(珠海)医院神经内科
作者简介:
基金信息:
the Project of Zunyi Science and Technology Plan(遵市科合社字(2018)20号);the "Fourteenth Five-Year Plan" of Clinical Key-Discipline Construction Program of Zhuhai, Guangdong Province(珠卫函〔2021〕115号)
Jingfan GUAN, Lulu AN, Jiangquan HAN, et al. Liraglutide ameliorates cerebral ischemic injury in diabetic rats by regulating microglia/macrophage polarization through inhibition of NOX2 expression[J]. Journal of Army Medical University, 2022, 44(11): 1136-1142.
DOI:
Jingfan GUAN, Lulu AN, Jiangquan HAN, et al. Liraglutide ameliorates cerebral ischemic injury in diabetic rats by regulating microglia/macrophage polarization through inhibition of NOX2 expression[J]. Journal of Army Medical University, 2022, 44(11): 1136-1142. DOI: 10.16016/j.2097-0927.202111090.
Liraglutide ameliorates cerebral ischemic injury in diabetic rats by regulating microglia/macrophage polarization through inhibition of NOX2 expression
To investigate the effects of liraglutide (Lir) on microglia/macrophage polarization and on the expression of nicotinamide adenine dinucleotide phosphate oxidase (NOX2) in the ischemic brain tissue of diabetic rats with focal cerebral ischemia.
Method
2
Seventy-five rats were randomly and equally divided into 5 groups: cerebral ischemia (CI) group
diabetes+cerebral ischemia (DCI) group
insulin treatment (Ins) group
Lir treatment (Lir) group
and NOX2 agonist tetrabromocinnamic acid (TBCA) + Lir group (TBCA). On the 3rd day after cerebral ischemia
the neurological deficit scores of the rats were evaluated
and 2
3
5-triphenyltetrazolium chloride (TTC) staining was adopted to measure the cerebral infarct volume in each group. The co-labeling of CD16/32 and CD206 with Iba1 on microglia/macrophages were detected by immunofluorescence double-label staining
and the protein expression of NOX2
TNF-α
IL-1β
IL-10 and TGF-β were determined using Western blotting.
Results
2
As co
mpared with the DCI group
the neurological deficit scores were decreased
and the cerebral infarction volume was reduced in the Lir group. The cell number of Iba1
+
/CD16/32
+
microglia/macrophage (M1 type) was declined
with down-regulated expression of TNF-α
IL-1β and NOX2 in the Lir group
while the number of Iba1
+
/CD206
+
microglia /macrophage (M2 type) was increased
with improved levels of IL-10 and TGF-β (all
P
<
0.05). However
the above effects were reversed by the treatment of NOX2 agonist TBCA (
P
<
0.05).
Conclusion
2
The neuroprotective effects of Lir on cerebral ischemic injury may be related to the inhibition of NOX2 expression and promotion of microglia/macrophages conversion to M2 type.
关键词
Keywords
references
JIANG Y H, LIU N, WANG Q Z, et al . Endocrine regulator rFGF21(recombinant human fibroblast growth factor 21) improves neurological outcomes following focal ischemic stroke of type 2 diabetes mellitus male mice[J ] . Stroke, 2018, 49(12): 3039-3049. DOI: 10.1161/STROKEAHA.118.022119.
BORGGREFE J, GLVCK B, MAUS V, et al . Clinical outcome after mechanical thrombectomy in patients with diabetes with major ischemic stroke of the anterior circulation[J ] . World Neurosurg, 2018, 120: e212-e220. DOI: 10.1016/j.wneu.2018.08.032.
BAI B, LI D F, XUE G F, et al . The novel GLP-1/GIP dual agonist DA3-CH is more effective than liraglutide in reducing endoplasmic Reticulum stress in diabetic rats with cerebral ischemia-reperfusion injury[J ] . Nutr Metab Cardiovasc Dis, 2021, 31(1): 333-343. DOI: 10.1016/j.numecd.2020.09.002.
HE J, HAN J Q, SHI N H, et al . Liraglutide protects against focal cerebral ischemic injury with diabetes mellitus by activating peroxisome proliferator-activated receptors[J ] . J Chongqing Med Univ, 2020, 45(3): 350-355. DOI: 10.13406/j.cnki.cyxb.001949.
SHI N H, HE J, GUO Q Q, et al . Liraglutide protects against diabetes mellitus complicated with focal cerebral ischemic injury by activating mitochondrial ATP-sensitive potassium channels[J ] . Neuroreport, 2019, 30(7): 479-484. DOI: 10.1097/WNR.0000000000001225.
MA S B, WANG J Y, WANG Y L, et al . Diabetes mellitus impairs white matter repair and long-term functional deficits after cerebral ischemia[J ] . Stroke, 2018, 49(10): 2453-2463. DOI: 10.1161/STROKEAHA.118.021452.
DARSALIA V, HUA S S, LARSSON M, et al . Exendin-4 reduces ischemic brain injury in normal and aged type 2 diabetic mice and promotes microglial M2 polarization[J ] . PLoS One, 2014, 9(8): e103114. DOI: 10.1371/journal.pone.0103114.
JACKSON-COWAN L, ELDAHSHAN W, DUMANLI S, et al . Delayed administration of angi otensin receptor(AT2R) agonist C21 improves survival and preserves sensorimotor outcomes in female diabetic rats post-stroke through modulation of microglial activation[J ] . Int J Mol Sci, 2021, 22(3): 1356. DOI: 10.3390/ijms22031356.
RUSSO M V, MCGAVERN D B. Inflammatory neuroprotection following traumatic brain injury[J]. Science, 2016, 353(6301): 783-785. DOI: 10.1126/science.aaf6260.
DING M, FANG Q H, CUI Y T, et al . Liraglutide prevents β-cell apoptosis via inactivation of NOX2 and its related signaling pathway[J ] . J Diabetes Complications, 2019, 33(4): 267-277. DOI: 10.1016/j.jdiacomp.2018.12.013.
KUROKI T, TANAKA R, SHIMADA Y, et al . Exendin-4 inhibits matrix metalloproteinase-9 activation and reduces infarct growth after focal cerebral ischemia in hyperglycemic mice[J ] . Stroke, 2016, 47(5): 1328-1335. DOI: 10.1161/strokeaha.116.012934.
CERECEDO-LOPEZ C D, CANTU-ALDANA A, PATEL N J, et al . Insulin in the management of acute ischemic stroke: a systematic review and meta-analysis[J ] . World Neurosurg, 2020, 136: e514-e534. DOI: 10.1016/j.wneu.2020.01.056.
MA Y Y, WANG J X, WANG Y T, et al . The biphasic function of microglia in ischemic stroke[J ] . Prog Neurobiol, 2017, 157: 247-272. DOI: 10.1016/j.pneurobio.2016.01.005.
HU X M, LEAK R K, SHI Y J, et al . Microglial and macrophage polarization—new prospects for brain repair[J ] . Nat Rev Neurol, 2015, 11(1): 56-64. DOI: 10.1038/nrneurol.2014.207.
MCCLEAN P L, PARTHSARATHY V, FAIVRE E, et al . The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease[J ] . J Neurosci, 2011, 31(17): 6587-6594. DOI: 10.1523/JNEUROSCI.0529-11.2011.
PARTHSARATHY V, HÖLSCHER C. The type 2 diabetes drug liraglutide reduces chronic inflammation induced by irradiation in the mouse brain[J]. Eur J Pharmacol, 2013, 700(1/2/3): 42-50. DOI: 10.1016/j.ejphar.2012.12.012.
BARRETO-VIANNA A R C, AGUILA M B, MANDARIM-DE-LACERDA C A. Beneficial effects of liraglutide(GLP1 analog) in the hippocampal inflammation[J]. Metab Brain Dis, 2017, 32(5): 1735-1745. DOI: 10.1007/s11011-017-0059-4.
ZENG X Z, REN H L, ZHU Y N, et al . Gp91phox(NOX2) in activated microgl ia exacerbates neuronal damage induced by oxygen glucose deprivation and hyperglycemia in an in vitro model[J ] . Cell Physiol Biochem, 2018, 50(2): 783-797. DOI: 10.1159/000494243.
NAYERNIA Z, JAQUET V, KRAUSE K H. New insights on NOX enzymes in the central nervous system[J]. Antioxid Redox Signal, 2014, 20(17): 2815-2837. DOI: 10.1089/ars.2013.5703.
KUMAR A, ALVAREZ-CRODA D M, STOICA B A, et al . Microglial/macrophage polarization dynamics following traumatic brain injury[J ] . J Neurotrauma, 2016, 33(19): 1732-1750. DOI:10.1089/neu.2015.4268.
Phosphorylation of extracellular signalregulated protein kinase induced neuronal death under brain ischemia in diabetic rats
Early identification of delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage: development and validation of a multifactorial clinical prediction model
Regulation and mechanism of Gm49394 on islet-β cell apoptosis
Efficacy and safety of drug-eluting balloon dilatation for coronary bifurcation disease in diabetic patients
Iron ion polarizes macrophages to M1 subtype through ROS-acetyl-P53
Related Author
张建忠
景丽
郭风英
马轶
王一理
ZHENG Hui
TAO Yihao
JI Xiang
Related Institution
Department of Neurosurgery, the Second Affiliated Hospital of Chongqing Medical University
Department of Immunology, Faculty of Pharmacy and Laboratory Medicine, Army Medical University (Third Military Medical University)
Department of Laboratory Animal Science, College of Basic Medical Sciences, Faculty of Pharmacy and Laboratory Medicine, Army Medical University (Third Military Medical University)
Department of Pharmaceutical Analysis, Faculty of Pharmacy and Laboratory Medicine, Army Medical University (Third Military Medical University)
Department of Cardiology, Second Affiliated Hospital of Army Medical University (Third Military Medical University)